Medical News

RSS

Though progress made, global burden of HIV/AIDS requires greater, 'better' response

"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.

15 Dec 2012

LCSB, AxoGlia receive Michael J. Fox Foundation grant for Parkinson's project

AxoGlia Therapeutics SA, a biopharmaceutical company which drives the development of innovative neural stem/progenitor cell differentiation and neuroprotective therapeutics, today announced that it has been awarded a Rapid Response Innovative Award from The Michael J. Fox Foundation, for a project that is performed in collaboration with the Luxembourg Centre for Systems Biomedicine (LCSB).

15 Dec 2012

Examining developing country contributions to AIDS response

"World AIDS Day 2012 offered numerous personal stories in the global fight against HIV and AIDS, but perhaps the most intriguing story, however, was a policy one: How developing countries are making significant contributions to the fight against AIDS in their own countries,"

15 Dec 2012

Today is deciding time for states on health exchanges

The Associated Press reports that 19 states have turned down the idea of running health insurance exchanges, creating a daunting task for the federal government.

15 Dec 2012

HCCMIS adds Coventry National Network to enhance health-care provider network

HCC Medical Insurance Services, LLC, a provider of worldwide medical insurance, has enhanced their health-care provider network by adding the Coventry National Network, through First Health.

15 Dec 2012

Researchers identify 125 genetic components in temozolomide-resistant, GBM-derived cell line

University of Pittsburgh Cancer Institute (UPCI) researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line, which could offer new hope for drug treatment to destroy the cancer cells.

15 Dec 2012

UMass Medical School to assist New Hampshire's Disproportionate Share Hospital program

The New Hampshire Department of Health and Human Services has awarded a three-year contract to UMass Medical School to assist with New Hampshire's Disproportionate Share Hospital program.

15 Dec 2012

WHO releases new guidelines for interventions aimed at protecting sex workers from HIV

The WHO on Wednesday "released new guidelines providing technical recommendations on effective interventions for the prevention and treatment of HIV and other sexually transmitted infections (STIs) among sex workers and their clients," New Europe Online reports.

15 Dec 2012

Study describes new, paradoxical characteristics of HER2-negative breast cancer

A multicenter study led by researchers at UC Davis describes new, paradoxical characteristics of the most common type of breast cancer. The findings shed light on how the disease can evade treatment and could improve diagnosis and treatment of breast cancer.

15 Dec 2012

New Global Burden of Disease Study provides 'data-rich framework' for global health conversations

"The World Bank Group welcomes the publication of the new Global Burden of Disease Study (GBD)," published in the Lancet on Thursday, World Bank Group President Jim Yong Kim writes in a Lancet opinion piece, adding, "The GBD gives us a data-rich framework for comparing the importance of different diseases, injuries, and risk factors in causing premature death and disability within and across populations."

15 Dec 2012

States getting arms around Medicaid expansion, challenges in own Medicaid programs

The health law's treatment of using Medicaid to expand coverage to more Americans is examined in Georgia -- where a doctor pay raise in the program has stirred discontent -- and in Oregon, where 200,000 stand to qualify under the program's expansion.

15 Dec 2012

Aerobic training the best mode of exercise for burning fat

Aerobic training is the best mode of exercise for burning fat, according to Duke researchers who compared aerobic training, resistance training, and a combination of the two.

15 Dec 2012

AcelRx announces top-line data from Sufentanil NanoTab PCA System Phase 3 trial

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that top-line data from its previously announced open-label, active-comparator study of its lead product candidate, the Sufentanil NanoTab PCA System, will be featured in poster presentations to be held at the 66th annual New York State Society of Anesthesiologists PostGraduate Assembly meeting in New York City to be held December 14-18, 2012.

15 Dec 2012

Schizophrenia tends to be elevated in more urban communities: Study

Higher rates of schizophrenia in urban areas can be attributed to increased deprivation, increased population density and an increase in inequality within a neighbourhood, new research reveals.

15 Dec 2012

New partnership to promote good nutrition in early childcare and education programs

Today, Dole Food Company and Lt. Governor Casey Cagle's Healthy Kids Georgia Program announced a partnership with the Georgia Department of Early Care and Learning to promote good nutrition and increased physical activity in early childcare and education programs.

15 Dec 2012

Patheon acquires Banner Pharmacaps

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has completed its acquisition of Banner Pharmacaps, a specialty pharmaceutical business dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

15 Dec 2012

Everolimus therapy might treat Myc-driven lymphoma

Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 percent of human cancers driven by alterations in the Myc gene, according to data from a preclinical study published in Cancer Discovery, a journal of the American Association for Cancer Research.

15 Dec 2012

Medical News

Though progress made, global burden of HIV/AIDS requires greater, 'better' response

LCSB, AxoGlia receive Michael J. Fox Foundation grant for Parkinson's project

Examining developing country contributions to AIDS response

Today is deciding time for states on health exchanges

HCCMIS adds Coventry National Network to enhance health-care provider network

Researchers identify 125 genetic components in temozolomide-resistant, GBM-derived cell line

UMass Medical School to assist New Hampshire's Disproportionate Share Hospital program

WHO releases new guidelines for interventions aimed at protecting sex workers from HIV

Study describes new, paradoxical characteristics of HER2-negative breast cancer

New Global Burden of Disease Study provides 'data-rich framework' for global health conversations

States getting arms around Medicaid expansion, challenges in own Medicaid programs

Aerobic training the best mode of exercise for burning fat

AcelRx announces top-line data from Sufentanil NanoTab PCA System Phase 3 trial

Schizophrenia tends to be elevated in more urban communities: Study

New partnership to promote good nutrition in early childcare and education programs

Patheon acquires Banner Pharmacaps

Everolimus therapy might treat Myc-driven lymphoma

Research provides broader understanding of processes that lead to Alzheimer's disease

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

Challenges, questions loom over health law implementation

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News